Skip To Content
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Type
All
AllStoriesVideoAudioGraphicsBusinessweek
Sort
By Newest
By NewestBy RelevanceBy Oldest
Time
Any Time
Any TimeLast 24 HoursPast WeekPast Month

Showing results for "Flexion"

relates to Swiss Investment Firm Longbow Finance Reveals Big Bet on Microsoft (MSFT)
wealth
Swiss Investment Firm Longbow Finance Reveals Big Bet on Microsoft (MSFT)
By Benjamin Stupples
Longbow Finance, an investment firm for the Rausing family, disclosed for the first time its $742.4 million portfolio of publicly traded US companies.
March 17, 2023
relates to Kedge Capital: Swiss Billionaire’s Firm for Hedge Fund Bets Taps World’s Rich
wealth
Kedge Capital: Swiss Billionaire’s Firm for Hedge Fund Bets Taps World’s Rich
By Benjamin Stupples
Kedge Capital, which invests in private equity and hedge funds for Ernesto Bertarelli and his family, is seeking to raise more than $1 billion.
October 25, 2022
relates to Scoliosis Brace Innovation Can Spare Kids Pain
businessweek
Scoliosis Brace Innovation Can Spare Kids Pain
By Amanda Kolson Hurley
The back brace has barely advanced since the 1970s. My journey through the latest gear—and surgical options—showed me how far is left to go.
May 20, 2022
relates to GBL Said Near to $1.7 Billion Affidea Deal With Swiss Tycoon
markets
GBL Said Near to $1.7 Billion Affidea Deal With Swiss Tycoon
By Manuel Baigorri and Aaron Kirchfeld
April 17, 2022
relates to Emerson Jumps Into Software Deals Scramble
business
Emerson Jumps Into Software Deals Scramble
By Liana Baker
Welcome to the Bloomberg Deals newsletter. Today: Emerson confirms its AspenTech deal, another supermarket tie-up gets snagged in France and barbarians are bowing out.
October 11, 2021
relates to Pacira To Pay $630 Million to Gain Flexion’s Pain Therapies
business
Pacira To Pay $630 Million to Gain Flexion’s Pain Therapies
By Michelle F Davis
Pacira BioSciences Inc. said it agreed to acquire Flexion Therapeutics Inc. in a $630 million deal that boosts the specialty biopharmaceutical company’s portfolio of non-opioid pain-relief therapies.
October 11, 2021
relates to Boston’s Biotechs Pull Out All the Stops in Hiring Boom ‘On Steroids’
business
Boston’s Biotechs Pull Out All the Stops in Hiring Boom ‘On Steroids’
By Angelica Peebles
Higher salaries, loftier titles and generous allowances for running shoes
July 28, 2021
relates to Bill Miller’s Hedge Fund Rose 120% in 2019 After Fast Finish
markets
Bill Miller’s Hedge Fund Rose 120% in 2019 After Fast Finish
By Melissa Karsh
Legendary investor Bill Miller’s hedge fund jumped 120% last year -- and he says it’s because he didn’t stray from his top names.
January 23, 2020
business
Baystate Business: The Fed, Moderna, Flexion, CVS (Radio)
On the Tuesday, February 20 edition of Bloomberg Baystate Business we spoke with State Street Senior Economist Simona Mocuta about the Fed minutes, the markets, and the state of the U.S. economy. Greg Sullivan of the Pioneer Institute talked about their new study that show the state’s unfunded pension liability continues to grow, despite the strong economy. Anne Mostue reported on the latest news from Moderna Therapeutics. Janet Wu spoke with Boston Mayor Marty Walsh about the city’s AAA bond
February 20, 2019
business
Bay State Biotech Report: Flexion Treating Knee OA
Flexion Therapeutics presents findings from Phase 2 study in patients with knee osteoarthritis and Type 2 diabetes that show Zilretta avoids significant rise in blood glucose seen with an immediate-release corticosteroid. That’s on the Bay State Biotech Report, where Bloomberg biotechnology reporter Doni Bloomfield and Boston radio host Anne Mostue discuss the latest in biotech news from the Boston area and across the nation.
June 14, 2017